2940
Y. D. Wang et al. / Tetrahedron 60 (2004) 2937–2942
24.9 mmol). After stirring for 15 min, a solution of 9
(2.86 g, 9.0 mmol) in tetrahydrofuran (100 mL) was added
dropwise over 30 min. The mixture was stirred at 278 8C
for 30 min then allowed to come to room temperature. The
reaction mixture was cooled to 278 8C and acetic acid
(3 mL) was added. The reaction mixture was allowed to
warm to room temperature. The solids were collected by
filtration washing with water, methanol, and ethyl acetate to
provide 10 (1.11 g, 44%) as a light yellow solid; mp
.300 8C; 1H NMR (d, ppm, DMSO-d6): 3.93 (s, 3H), 4.00
(s, 3H), 7.29 (s, 1H), 7.60 (s, 1H), 8.68 (s, 1H), 8.97 (s, 1H);
m/z (ES) (MH)þ¼281.9. Anal. Calcd for C15H11N3O3
20.65 H2O: C, 61.49; H, 4.23; N, 14.34. Found: C, 61.40;
H, 4.40; N, 14.70.
graphed (ethyl acetate/hexanes 1:3) to give 13a as a yellow
1
solid (762 mg, 90%); mp 148–150 8C; H NMR (d, ppm,
DMSO-d6): 1.38 (t, J¼5 Hz, 3H), 4.40 (q, J¼5 Hz, 2H),
6.42 (s, 2H), 7.41 (dt, J¼5, 1 Hz, 1H), 7.47 (dt, J¼5, 1 Hz,
1H), 7.51 (s, 1H), 7.67 (d, J¼5 Hz, 1H), 7.86 (d, J¼5 Hz,
1H); m/z (ES) (MH)þ¼217.1. Anal. Calcd for C12H12N2O2
20.10H2O: C, 66.10; H, 5.62; N, 12.85. Found: C, 65.82; H,
5.50; N, 12.74.
3.3.2. Ethyl 3-amino-6,7-dimethoxy-2-quinolinecar-
boxylate (13b). Following the route used to prepare 13a,
13b was obtained from 2-amino-4,5-dimethoxybenzalde-
hyde (1.0 g, 4.74 mmol) as a yellow solid (1.04 g, 79%); mp
168–170 8C; 1H NMR (d, ppm, DMSO-d6): 1.35 (t,
J¼5 Hz, 3H), 3.32 (s, 6H), 4.35 (q, J¼5 Hz, 2H), 6.31 (s,
br, 2H), 7.00 (s, 1H), 7.16 (s, 1H), 7.40 (s, 1H); m/z (ES)
(MH)þ¼277.2. Anal. Calcd for C14H16N2O4 20.10 H2O:
C, 60.46; H, 5.85; N, 10.08. Found: C, 60.20; H, 6.00; N,
9.91.
3.2.5. 4-Chloro-7,8-dimethoxybenzo[b][1,8]-naphthyri-
dine-3-carbonitrile (11). A mixture of 10 (500 mg,
1.8 mmol) and phosphorous oxychloride (5 mL) was heated
at reflux for 1 h. The reaction mixture was cooled to room
temperature and hexane was added. The resultant solid was
collected by filtration washing with hexane, water, methanol
and ethyl acetate to provide 11 (258 mg, 49%) as a brown
solid; mp .300 8C; 1H NMR (d, ppm, DMSO-d6): 4.01 (s,
3H), 4.07 (s, 3H), 7.58 (s, 1H), 7.77 (s, 1H), 9.27 (s, 1H),
9.34 (s, 1H); m/z (ES) (MH)þ¼299.9. Anal. Calcd for
C15H10ClN3O2 20.40 H2O: C, 58.70; H, 3.55; N, 13.69.
Found: C, 58.85; H, 3.33; N, 13.97.
2-Amino-4,5-dimethoxybenzaldehyde was prepared as
follows: A mixture of 3,4-dimethoxy-6-nitrobenzaldehyde
(2.0 g, 9,47 mmol) and 10% Pd–C (200 mg) in ethanol
(50 mL) was hydrogenated at 40 psi for 2 h. The resulting
suspension was filtered and washed with ethanol. The
filtrate was used directly in the next step.
3.3.3. Ethyl 3-amino-6-chloro-2-quinolinecarboxylate
(13c). Following the route used to prepare 13a, 13c was
obtained from 2-amino-5-chlorobenzaldehyde (500 mg,
3.21 mmol) as a yellow solid (385 mg, 48%): mp 151–
153 8C; 1H NMR (d, ppm, DMSO-d6): 1.37 (t, J¼5 Hz, 3H),
4.41 (q, J¼5 Hz, 2H), 6.58 (s, 2H), 7.36 (dt, J¼7, 2 Hz, 1H),
7.46 (s, 1H), 7.82 (d, J¼2 Hz, 1H), 7.85 (d, J¼7 Hz, 1H);
m/z (ES) (MH)þ¼251.1. Anal. Calcd for C12H11ClN2O2
20.1 C4H8O2: C, 57.39; H, 4.57; N, 10.80. Found: C, 57.35;
H, 4.33; N, 10.53.
3.2.6. 4-(2,4-Dichloro-5-methoxyanilino)-7,8-dimethoxy-
benzo[b][1,8]naphthyridine-3-carbonitrile (4). A mixture
of 11 (150 mg, 0.50 mmol), 2,4-dichloro-5-methoxyaniline
(160 mg, 0.83 mmol) and pyridine hydrochloride (70 mg,
0.60 mmol) in 2-ethoxyethanol (15 mL) was heated at reflux
for 25 min. The resultant black solution was cooled to room
temperature and partitioned between ethyl acetate and
saturated aqueous sodium bicarbonate. The organic layer
was dried over magnesium sulfate, filtered and concentrated
in vacuo to provide 143 mg of a 10:1 mixture of 4 and 10.
This material was dissolved in ethyl acetate and washed
with a solution of saturated aqueous sodium bicarbonate and
sodium hydroxide (pH 11) to remove 10. The organic layer
was dried over magnesium sulfate, filtered and reduced in
vacuo to about 10 mL. The solids were collected by
filtration washing with diethyl ether to provide 4 (86 mg,
3.3.4. Ethyl 3-amino-7-chloro-2-quinolinecarboxylate
(13d). Following the route used to prepare 13a, 13d was
obtained from 2-amino-4-chlorobenzaldehyde9 (500 mg,
3.21 mmol) as a yellow solid (71%); mp 128–130 8C;
1H NMR (d, ppm, DMSO-d6): 1.37 (t, J¼5 Hz, 3H), 4.40
(q, J¼5 Hz, 2H), 6.51 (s, 2H), 7.48 (dt, J¼7, 2 Hz, 1H),
7.55 (s, 1H), 7.74 (d, J¼7 Hz, 1H), 7.90 (d, J¼2 Hz,
1H); m/z (ES) (MH)þ¼251.0. Anal. Calcd for
C12H11ClN2O2: C, 57.50; H, 4.42; N, 11.17. Found: C,
57.38; H, 4.22; N, 11.05.
1
38%) as a bright orange solid; mp .290 8C; H NMR (d,
ppm, DMSO-d6): 3.82 (s, 3H), 3.92 (s, 3H), 4.00 (s, 3H),
6.78 (s, 1H), 7.28 (s, 1H), 7.47 (s, 1H), 7.62 (s, 1H), 8.28 (s,
1H), 9.19 (s, 1H); m/z (ES) (MH)þ¼455.0. Anal. Calcd for
C22H16Cl2N4O3: C, 58.04; H, 3.54; N, 12.31. Found: C,
57.86; H, 3.48; N, 12.30.
3.3.5. Ethyl 3-amino-6,8-dibromo-2-quinolinecarboxyl-
ate (13e). Following the route used to prepare 13a, 13e
was obtained from 2-amino-3,5-dibromobenzaldehyde
(896 mg, 3.21 mmol) as a yellow solid (470 mg, 39%);
mp 143–145 8C; 1H NMR (d, ppm, DMSO-d6): 1.36
(t, J¼5 Hz, 3H); 4.41 (q, J¼5 Hz, 2H), 6.71 (s, br, 2H),
7.48 (s, 1H), 7.88 (d, J¼2 Hz, 1H), 8.03 (d, J¼2 Hz, 1H);
(m/z (ES) (MH)þ¼374.9. Anal. Calcd for C12H10Br2N2O2:
C, 38.53; H, 2.53; N, 7.49. Found: C, 38.22; H, 2.53; N,
7.30.
3.3. Compounds 13a-13h
3.3.1. Ethyl 3-amino-2-quinolinecarboxylate (13a). To a
mixture of pyridine (342 mg, 4.34 mol) and ethanol (12 mL)
was added ethyl 2-bromopyruvate (846 mg, 4.34 mmol) in
ethanol (8 mL) dropwise over 20 min. The resulting mixture
was heated at 60–70 8C for one hour and cooled to room
temperature.
ortho-Aminobenzaldehyde
(500 mg,
4.13 mmol) and pyridine (0.80 mL) were added. After
heating at reflux for 5 h, pyrrolidine (698 mg, 9.83 mmol)
was added. The resulting mixture was heated for an
additional 2 h and concentrated. The residue was chromato-
3.3.6. 2-Phenyl-quinoline-3-ylamine (13f). A mixture of
1-phenacylpyridinium bromide (1.20 g, 4.34 mmol), ortho-
aminobenzaldehyde (0.5 g, 4.13 mmol), pyridine (0.2 mL)